David V Smith's Net Worth
$7.8 Million
Who is David V Smith?
David V Smith has an estimated net worth of $7.8 Million. This is based on reported shares across multiple companies, which include CODEXIS, INC., THORATEC CORP, IO Biotech, Inc., ONCOGENEX PHARMACEUTICALS, INC., FIVE PRIME THERAPEUTICS, INC., and CHIRON CORP.
SEC CIK
David V Smith's CIK is 0001229447
Past Insider Trading and Trends
2020 was David V Smith's most active year for acquiring shares with 7 total transactions. David V Smith's most active month to acquire stocks was the month of May. 2006 was David V Smith's most active year for disposing of shares, totalling 10 transactions. David V Smith's most active month to dispose stocks was the month of March. 2010 saw David V Smith paying a total of $527,400.00 for 70,702 shares, this is the most they've acquired in one year. In 2021 David V Smith cashed out on 518,009 shares for a total of $5,411,364.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CODEXIS, INC. (CDXS) Snapshot price: $2.74
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +87.05% | 30.12K |
—
|
—
| 64.72K |
Jun 11
| |||
Form 4
| +206.95% | 23.33K |
—
|
—
| 34.6K |
Jun 13
| |||
Form 4
| +135.05% | 6.48K |
—
|
—
| 11.27K |
Jun 14
| |||
Form 4
| -46.43% | -4.16K |
—
|
—
| 4.8K |
Jun 15
| |||
Form 4
| +80.96% | 4K |
—
|
—
| 8.95K |
Jun 11 - Jun 16
| |||
Form 4
|
∞
| 4.95K |
—
|
—
| 4.95K |
Jun 11
| |||
Form 4
|
∞
| 5.92K |
—
|
—
| 5.92K |
Jun 11
| |||
Form 4
| -9.57% | -6.00K |
$10.37 | -$62,212.80 | 56.68K |
Scheduled
|
Apr 3
| ||
Form 4
| +39.96% | 17.89K |
—
|
—
| 62.68K |
Jun 14
| |||
Form 4
| +81.38% | 20.09K |
—
|
—
| 44.78K |
Jun 15
| |||
Form 4
|
∞
| 24.69K |
—
|
—
| 24.69K |
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
THORATEC CORP No price found
CFO & EVP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.35% | -1.56K |
$27.17 | -$42,276.52 | 64.59K |
Mar 15
| |||
Form 4
| +25.95% | 13.63K |
$28.93 | -$39,634.10 | 66.15K |
Mar 1 - Mar 3
| |||
Form 4
| -5.07% | -2.81K |
$27.88 | -$78,246.27 | 52.52K |
Feb 25 - Feb 28
| |||
Form 4
| -5.33% | -3.11K |
$28.60 | -$89,003.20 | 55.32K |
Dec 29
| |||
Form 4
|
—
|
0
|
$30.98 | -$803,808.87 | 58.44K |
Scheduled
|
Jun 3
| ||
Form 4
| -2.59% | -1.56K |
$33.16 | -$51,596.96 | 58.44K |
Mar 15
| |||
Form 4
| +24.32% | 11.73K |
—
|
—
| 59.99K |
Mar 3
| |||
Form 4
| -5.47% | -2.79K |
$28.77 | -$80,272.38 | 48.26K |
Feb 25 - Mar 1
| |||
Form 4
| -5.75% | -3.11K |
$27.08 | -$84,300.04 | 51.05K |
Dec 29
| |||
Form 4
| -2.74% | -1.52K |
$22.69 | -$34,602.25 | 54.16K |
Mar 16
| |||
Form 4
| +20.08% | 9.31K |
$22.84 | -$33,963.08 | 55.69K |
Feb 25 - Feb 27
| |||
Form 4
| -6.17% | -3.05K |
$30.55 | -$93,208.05 | 46.37K |
Dec 29
| |||
Form 4
| -2.35% | -1.19K |
$13.09 | -$15,603.28 | 49.42K |
Mar 17
| |||
Form 4
| +34.56% | 13K |
—
|
—
| 50.62K |
Feb 27
| |||
Form 4
| -5.96% | -2.38K |
$18.19 | -$43,364.96 | 37.62K |
Dec 29
| |||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IO Biotech, Inc. (IOBT) Snapshot price: $0.843
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ONCOGENEX PHARMACEUTICALS, INC. (ACHV) Snapshot price: $4.165
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +35.71% | 2.5K |
—
|
—
| 9.5K |
May 20
| |||
Form 4
| +55.56% | 2.5K |
—
|
—
| 7K |
May 20 - May 21
| |||
Form 4
| +125.00% | 2.5K |
—
|
—
| 4.5K |
Jun 5
| |||
Form 4
|
∞
| 2K |
$10.64 | $21,280.00 | 2K |
May 23 - May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FIVE PRIME THERAPEUTICS, INC. No price found
Executive Vice President & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -72.95K |
$38.00 | -$5,279,986.00 |
0
|
Apr 16
| |||
Form 4
| -6.55% | -5.11K |
$25.71 | -$131,378.10 | 72.95K |
Feb 24
| |||
Form 4
| +15.54% | 10.5K |
$16.14 | -$185,674.56 | 78.06K |
Dec 11
| |||
Form 4
| -9.29% | -6.92K |
$18.45 | -$127,674.00 | 67.56K |
Nov 26
| |||
Form 4
| +17.50% | 11.09K |
$18.00 | -$196,344.00 | 74.48K |
Nov 11
| |||
Form 4
| +89.85% | 30K |
—
|
—
| 63.39K |
Feb 24
| |||
Form 4
| -16.53% | -6.61K |
$3.77 | -$24,923.47 | 33.39K |
Nov 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Nov 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||